Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL722643 | 1.00 | LMNA (0.35) | LMNAMAPK1POLBPKMPTPN1 | |
| SCHEMBL14525328 | 1.00 | LMNA (0.35) | LMNAMAPK1POLBPKMPTPN1 | |
| SCHEMBL11567410 | 0.78 | MEN1 (0.32) | LMNAKMT2A | |
| SCHEMBL14198755 | 0.78 | — | — | |
| SCHEMBL18901903 | 0.78 | MEN1 (0.32) | LMNAKMT2A | |
| SCHEMBL10598027 | 0.77 | NR1I2 (0.38) | LMNABLM | |
| SCHEMBL14138261 | 0.75 | — | — | |
| SCHEMBL18265835 | 0.72 | CA1 (0.33) | — | |
| SCHEMBL1977622 | 0.71 | — | — | |
| SCHEMBL22861792 | 0.71 | HTR1E (0.36) | LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539948-B | Aqueous binder and application thereof | 远景动力技术(江苏)有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-113189214-B | Large yellow croaker proliferation and releasing molecular marker and screening method thereof | 宁波大学 | 2022-06-21 | — | — | CN | claimed |
| CN-114539948-A | Aqueous binder and application thereof | 远景动力技术(江苏)有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-113189214-A | Large yellow croaker proliferation and releasing molecular marker and screening method thereof based on liquid phase-tandem mass spectrometry technology | 宁波大学 | 2021-07-30 | — | — | CN | claimed |
| CN-114539948-B | Aqueous binder and application thereof | 远景动力技术(江苏)有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-114539948-B | Aqueous binder and application thereof | 远景动力技术(江苏)有限公司 | 2023-12-05 | — | — | CN | disclosed |
| US-11739345-B2 | Methods of treating phenylketonuria | BIOMARIN PHARMACEUTICAL INC. (US) | 2023-08-29 | — | — | US | disclosed |
| CN-113189214-B | Large yellow croaker proliferation and releasing molecular marker and screening method thereof | 宁波大学 | 2022-06-21 | — | — | CN | disclosed |
| CN-112255335-B | Plasma metabolism marker for distinguishing benign ovarian tumor from malignant ovarian tumor and application thereof | 复旦大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-114539948-A | Aqueous binder and application thereof | 远景动力技术(江苏)有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114539948-A | Aqueous binder and application thereof | 远景动力技术(江苏)有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-113189214-A | Large yellow croaker proliferation and releasing molecular marker and screening method thereof based on liquid phase-tandem mass spectrometry technology | 宁波大学 | 2021-07-30 | — | — | CN | disclosed |
| CN-112255335-A | Plasma metabolic marker for distinguishing benign ovarian tumor from malignant ovarian tumor and application thereof | 复旦大学 | 2021-01-22 | — | — | CN | disclosed |
| WO-2019217513-A2 | METHODS OF TREATING PHENYLKETONURIA | BIOMARIN PHARMACEUTICAL INC. (US) | 2019-11-14 | — | — | WO | disclosed |
| WO-2012027369-A2 | SYSTEM AND METHOD FOR STRAIGHTENING OR SHAPING HAIR | DIVERSAPACK OF CALIFORNIA, LLC (US) | 2012-03-01 | — | — | WO | disclosed |
| EP-1016401-B1 | Hair cleansing composition | KAO CORP (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-6358502-B1 | FOR LUSTER, SOFTNESS, BODY | KAO CORPORATION (JP) | 2002-03-19 | — | — | US | disclosed |
| US-6348189-B1 | AND THE HYDROXY ACIDS, MALIC ACID AND MALEIC ACID; ANIONIC SURFACTANT SELECTED FROM AN ALKYLSULFURIC ACID SALT, AN ALKYLETHERSULFURIC ACID SALT, OR AN N-ALKYLAMIDO-ALKANOLSULFURIC ACID ESTER SALT; SHAMPOO | KAO CORPORATION (JP) | 2002-02-19 | — | — | US | disclosed |
| EP-1016401-A1 | Hair cleansing composition | Kao Corporation (JP) | 2000-07-05 | — | — | EP | disclosed |
| EP-1016402-A2 | Hair cosmetic composition | Kao Corporation (JP) | 2000-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739345-B2 | Methods of treating phenylketonuria | PAH, PNMT, AADAT | LMNA 2039/4885MAPK1 3887/4885POLB 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.